Perspectives by the Leerink Center for Pharmacoeconomics
Perspectives is a podcast series from the Leerink Center for Pharmacoeconomics, hosted by Dr. Mel Whittington. It features conversations with industry experts to explore the societal impact of healthcare innovations.
Episodes
Can Clinical Trial Failure Be Insured? A Conversation with Tomas Philipson
Dr. Tomas Philipson, former Acting Chairman of the White House Council of Economic Advisers and Professor Emeritus at the University of Chicago, joins Perspectives by the Leerink Center for Pharmacoeconomics to discuss a new insurance model he developed that insures biotech investments against clinical trial failure. He explains how this insurance could reshape the way risk is managed in life scie
Are We Pricing Drugs Right? A Conversation with Peter Neumann on How Innovation is Valued Globally
In this episode of Perspectives by the Leerink Center for Pharmacoeconomics, host Mel Whittington sits down with renowned health economist Dr. Peter Neumann following the annual meeting of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center. Drawing from conversations that took place at the meeting, Mel and Peter explore some of the questions that are shaping h
What’s Behind Drug Pricing: The Hidden Role and Limits of Cost-Effectiveness Analysis
In this episode of Perspectives by the Leerink Center for Pharmacoeconomics, Melanie Whittington breaks down a fundamental—and increasingly consequential—question in health economics: what counts as value in cost-effectiveness analysis?
For biotech leaders and investors, Mel cautions that this isn’t just an academic debate. The frameworks adopted by HTA bodies influence pricing, access, and ultima
Welcome to Perspectives by the Leerink Center for Pharmacoeconomics
In our signature podcast series, Dr. Mel Whittington, a health economist and Head of the Leerink Center for Pharmacoeconomics, talks with people from across the industry to hear their stories and to better understand the societal impact of healthcare innovations. If you’re interested in participating in future podcasts or would like to learn more about the Leerink Center for Pharmacoeconomics, ple
